Clinical trials during corona
a risk-based approach in the interest of patients and data
DURATION: 60 MINUTES
How to navigate your clinical trials in times of corona
Hospitals are over-burdened and people have to stay home as much as possible. How are we dealing with study visits and other aspects of the trials?
This webinar sheds light on a risk-based approach to ongoing trials and the international guidance that has been released, to protect trial subjects as much as possible and limit the damage to ongoing trials as much as possible.
WHAT YOU’LL LEARN
obtain insights in all aspects that are part of the consideration
Get informed about the international guidance released by both the ema and the fda
learn the possibilities for protecting the trials subjects in ongoing studies as best as possible
obtain insight in the considerations that come into play with the continuation of ongoing trials
About our webinar host
An expert trainer with over 20 years of practice, Eric’s depth of knowledge is astounding, and his enthusiastic teaching style makes him an extremely valuable asset to the GCP Central team.
As a master storyteller and facilitator, Eric delivers world-class training and keynotes that inspire, motivate and move audiences, around the world.